Inventor · disambiguated record
James Francis Hulvat
Also filed as: HULVAT JAMES F · HULVAT JAMES FRANCIS
5 granted patents·6 pending applications·112 citations·filing 2002–2020
82Inventor score
Files withPHARMACYCLICS LLC4UNIV NORTHWESTERN3ABLARIS THERAPEUTICS INC1ASSEMBLY BIOSCIENCES INC1HULVAT JAMES F1
Top patents by PatentIndex Score
11 records- 0192US9545407B2Formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2015·Granted Jan 17, 2017·51 cites·6 claims
- 0292US7851445B2Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of useUNIV NORTHWESTERN·Filed 2006·Granted Dec 14, 2010·33 cites·12 claims
- 0385US8076295B2Peptide amphiphiles having improved solubility and methods of using sameHULVAT JAMES F·Filed 2008·Granted Dec 13, 2011·14 cites·28 claims
- 0462US6680215B2Liquid crystal-templated conducting organic polymersUNIV NORTHWESTERN·Filed 2002·Granted Jan 20, 2004·7 cites·24 claims
- 0558US7371887B2Oligo(p-phenylene vinylene) amphiphiles and methods for self-assemblyUNIV NORTHWESTERN·Filed 2004·Granted May 13, 2008·7 cites·25 claims
- 0655US2019282578A1Novel formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 0751US2018028537A1Novel Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 0850US2017079981A1Novel Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 0949US2022241208A1Pharmaceutical compositions for the treatment of hbvASSEMBLY BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1048US2022048900A1Amorphous sparsentan compositionsTRAVERE THERAPUETICS INC·Filed 2019·Application pending·0 cites
- 1141US2013237476A1Adipose tissue targeted peptidesABLARIS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Francis Hulvat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →